Diet-drug makers grab sector spotlight
June 03, 2011 at 11:27 AM EDT
Diet-drug makers Orexigen, Vivus and Arena grabbed the sector spotlight early Friday, falling on news that Orexigen is halting its obesity-therapy program due to regulatory problems.
